Endonovo Therapeutics, Inc. (ENDV)
0.0000
0.00 (0.00%)
USD |
OTCM |
Aug 28, 16:00
Endonovo Therapeutics Free Cash Flow : -0.1174M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1174M |
| March 31, 2026 | -0.0924M |
| December 31, 2025 | -0.043M |
| September 30, 2025 | 0.0682M |
| June 30, 2025 | 0.0766M |
| March 31, 2025 | 0.1025M |
| December 31, 2024 | 0.1005M |
| September 30, 2024 | 0.524M |
| June 30, 2024 | 0.4597M |
| March 31, 2024 | 0.2928M |
| December 31, 2023 | 0.1219M |
| September 30, 2023 | -0.6299M |
| June 30, 2023 | -0.6884M |
| March 31, 2023 | -0.729M |
| December 31, 2022 | -0.6788M |
| September 30, 2022 | -0.8446M |
| June 30, 2022 | -0.8901M |
| March 31, 2022 | -0.8196M |
| December 31, 2021 | -0.9866M |
| September 30, 2021 | -0.7881M |
| June 30, 2021 | -0.7154M |
| March 31, 2021 | -0.7343M |
| December 31, 2020 | -0.7416M |
| September 30, 2020 | -0.8571M |
| June 30, 2020 | -1.778M |
| Date | Value |
|---|---|
| March 31, 2020 | -2.313M |
| December 31, 2019 | -2.544M |
| September 30, 2019 | -2.951M |
| June 30, 2019 | -2.764M |
| March 31, 2019 | -2.816M |
| December 31, 2018 | -2.888M |
| September 30, 2018 | -5.972M |
| June 30, 2018 | -5.983M |
| March 31, 2018 | -6.155M |
| December 31, 2017 | -5.990M |
| September 30, 2017 | -2.848M |
| June 30, 2017 | -2.782M |
| March 31, 2017 | -2.445M |
| December 31, 2016 | -2.462M |
| September 30, 2016 | -2.030M |
| June 30, 2016 | -1.684M |
| March 31, 2016 | -1.292M |
| December 31, 2015 | -1.035M |
| September 30, 2015 | -1.036M |
| June 30, 2015 | -0.8027M |
| March 31, 2015 | -0.9072M |
| December 31, 2014 | -0.9093M |
| September 30, 2014 | -0.4712M |
| June 30, 2014 | -0.5673M |
| March 31, 2014 | -0.3371M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Anika Therapeutics, Inc. | 0.562M |
| Accuray, Inc. | -19.26M |
| Micron Solutions, Inc. | -- |
| Perspective Therapeutics, Inc. | -121.38M |
| Orthofix Medical, Inc. | -26.93M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -0.0498M |
| Cash from Financing (Quarterly) | 0.075M |
| Free Cash Flow to Equity (Quarterly) | -0.1248M |
| Free Cash Flow to Firm (Quarterly) | 0.2595M |
| Free Cash Flow Yield | -129.9% |